Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) belongs to the Healthcare Technology segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. EKG's top 3 sector exposures are Health Care and Financials. In contrast, PBE's top sector exposures are Health Care EKG is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.58% for PBE. EKG is down -13.25% year-to-date (YTD) with - in YTD flows. PBE performs better with -7.12% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of EKG and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | EKG PBE | -4.00%-6.52% | -14.51%-5.52% | -13.25%-7.12% | +2.95%+19.22% | +0.49%+26.51% | n/a+1.84% |
| Flows | EKG PBE | --$3M | -+$969K | -+$135K | -$25K-$32M | +$1M-$56M | --$39M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | EKG PBE | +20.20%+18.95% | +24.28%+22.28% | +22.65%+20.18% | n/a+22.77% |
| Max drawdown | EKG PBE | -18.32%-11.05% | -18.32%-16.18% | -34.97%-22.21% | n/a-34.74% |
| Max drawdown duration | EKG PBE | 64d65d | 64d107d | 563d324d | n/a1540d |
EKG | PBE | |
Last sale 3/13/2026 at 1:30 PM | $16.43 | $76.18 |
| Previous close 03/12/2026 | $16.47 | $76.18 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
EKG | PBE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
EKG | PBE | |
|---|---|---|
| Last price | $16.43 | $76.18 |
| 1D performance | -0.25% | +0.00% |
| AuM | $2.47 M | $240.98 M |
| E/R | 0.65% | 0.58% |
EKG | PBE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | Invesco |
| Benchmark | Nasdaq Lux Health Tech Index | Dynamic Biotech & Genome Intellidex Index |
| N° of holdings | 36 | 30 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | March 22, 2022 | June 23, 2005 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
